EID Parry (India) Limited reported a significant contraction in profitability for the first quarter of fiscal year 2027 (Q1FY27), with consolidated profit after tax (PAT) falling 42% year-on-year to ₹142 crore. While consolidated revenue from operations grew 3.4% to ₹9,017 crore against ₹8,720 crore in the corresponding quarter of the previous year, earnings before interest, tax, depreciation, and amortization (EBITDA) declined to ₹781 crore from ₹895 crore. The standalone business reported a loss after tax of ₹89 crore, compared to a loss of ₹28 crore in Q1FY26, primarily impacted by exceptional items including a net impairment charge of ₹19 crore on investments in its subsidiary, Parry Sugars Refinery India Private Limited (PSRIPL).

The Board of Directors, led by Whole-Time Director and Chief Executive Officer Muthiah Murugappan, approved the unaudited financial results on August 12, 2026. The results were reviewed by the Audit Committee and independently audited by Price Waterhouse Chartered Accountants LLP pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The auditor’s report notes that the financial statements have been prepared in accordance with Ind AS 34 and other generally accepted accounting principles in India.

Segment Performance

The Farm Inputs division, primarily through its subsidiary Coromandel International Limited, remained the primary profit driver, reporting a profit before interest and tax (LBIT) of ₹649 crore, down from ₹741 crore in the prior year quarter. Conversely, the Sugar & Biofuel division recorded an LBIT loss of ₹58 crore, widening from a loss of ₹30 crore previously. This deterioration was attributed to higher operational costs and one-time expenses that offset benefits from increased sales volumes.

The Distillery segment saw revenues decline 14% to ₹255 crore due to lower off-take of Extra Neutral Alcohol (ENA) by IMFL manufacturers in Tamil Nadu, resulting in a profit drop to ₹9 crore from ₹20 crore. Meanwhile, the Nutraceuticals division turned profitable, reporting an LBIT of ₹0.11 crore against a loss of ₹10 crore, driven by stronger performance from its US subsidiary, US Nutraceuticals Inc.

Standalone Operational Challenges

Standalone revenue from operations contracted 3% to ₹733 crore from ₹756 crore. The Sugar segment within the standalone books grew 18% to ₹410 crore, fueled by higher sales volumes, but this did not translate to margin improvement as operational costs rose. The Consumer Products Group (CPG) reported a sharp revenue decline to ₹94 crore from ₹188 crore, though management noted improved operating margins due to a recalibrated operating model focused on profitability over volume.

What the Numbers Show

A critical divergence exists between the company’s top-line growth and bottom-line performance. While consolidated revenue expanded, the EBITDA margin compressed significantly, dropping from approximately 10.3% in Q1FY26 to 8.7% in Q1FY27. This margin erosion is largely attributable to the underperformance of the Sugar & Biofuel and Distillery segments, which failed to leverage volume gains into profitability. Furthermore, the standalone entity’s reliance on exceptional items—specifically the reversal of financial guarantee provisions and impairment charges related to PSRIPL—highlights ongoing structural risks in the refinery business unit, which continues to weigh on overall group stability despite the robust performance of the Farm Inputs division.

EID Parry has confirmed the retirement of Dr. Rea Godbole as an Independent Director, effective August 4, 2026. The change in board composition follows the completion of her tenure of two consecutive terms, marking the end of her service on the Board. This transition is part of the company’s routine governance cycle and ensures compliance with regulatory norms regarding director tenure limits.

The announcement was made via a disclosure to BSE Limited and National Stock Exchange of India Limited on August 4, 2026. The filing cites Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Para A (7) of Part A of Schedule III. Additionally, the company referenced SEBI Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, which mandates specific disclosures regarding changes in key managerial personnel and directors.

Key Details of Retirement

Dr. Godbole ceased to hold office at the close of business hours on August 4, 2026. The company stated that there are no further disclosures required regarding relationships between directors or brief profiles, as these fields are not applicable for retirement events.

Regulatory Compliance

Biswa Mohan Rath, Company Secretary of E.I.D. - Parry (India) Limited, signed the disclosure document digitally on August 4, 2026. The filing ensures transparency for investors regarding the stability and composition of the Board. No other changes to key managerial personnel, senior management, auditors, or compliance officers were reported in this specific disclosure.

What This Means for Stakeholders

The retirement of an Independent Director is a standard governance event. Investors should note that the company must appoint a new Independent Director to maintain the required ratio of independent directors on the Board, as per SEBI guidelines. While this filing does not announce a successor, it signals that the Board will likely initiate a nomination process in the near term to fill the vacancy.